{
  "trial_id": "NCT00022971",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Diagnosis of B-cell lymphoma, Waldenstrom's CLL with surface expression of both CD20 and 1D10 antigen by immunohistochemistry (IHC) or fluorescence of activated cell sorting (FACS)",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Confirmation of diagnosis in Laboratory of Pathology, NCI or OSU.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Prior therapy with at least one systemic treatment, and not a candidate for potentially curative (i.e., transplant) treatment at the time of study entry.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Age greater than 18 years.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "ECOG performance status less than or equal to 2.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Major organ function: ANC greater than or equal to 500/microliter, Platelet greater than or equal 25,000/microliter, Creatinine less than or equal to 1.5 mg/dl or creatinine clearance greater than 60 cc/min; SGPT less than 5 x upper limit of normal; bilirubin less than 2 mg/dl (total) except less than 5 mg/dl in patients with Gilbert's syndrome as defined by greater than 80% unconjugated; unless impairment due to organ involvement by lymphoma.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Provides informed consent.",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Pregnancy or nursing. Both male and female patients must be willing to use adequate contraception.",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Prior apolizumab treatment.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "SActive cardiac disease, cerebrovascular disease or peripheral arterial vascular disease.",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Active CNS lymphoma.",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Systemic cytotoxic chemotherapy within 3 weeks of enrollment or systemic steroids (except stable doses less than 10 mg/day) within 1 week of enrollment.",
      "label": "not_met",
      "evidence": "quote"
    }
  ],
  "notes": "Patient has a history of PCOS, Obesity, HTN and was diagnosed with Burkitt's lymphoma. They have undergone treatment and are currently stable.",
  "_meta": {
    "topic_id": "4",
    "trial_id": "NCT00022971",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}